AU2002324701A1 - Gene expression profiles in glomerular diseases - Google Patents
Gene expression profiles in glomerular diseasesInfo
- Publication number
- AU2002324701A1 AU2002324701A1 AU2002324701A AU2002324701A AU2002324701A1 AU 2002324701 A1 AU2002324701 A1 AU 2002324701A1 AU 2002324701 A AU2002324701 A AU 2002324701A AU 2002324701 A AU2002324701 A AU 2002324701A AU 2002324701 A1 AU2002324701 A1 AU 2002324701A1
- Authority
- AU
- Australia
- Prior art keywords
- gene expression
- expression profiles
- glomerular diseases
- glomerular
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31183701P | 2001-08-14 | 2001-08-14 | |
US60/311,837 | 2001-08-14 | ||
PCT/US2002/025766 WO2003016476A2 (en) | 2001-08-14 | 2002-08-14 | Gene expression profiles in glomerular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002324701A1 true AU2002324701A1 (en) | 2003-03-03 |
Family
ID=23208719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002324701A Abandoned AU2002324701A1 (en) | 2001-08-14 | 2002-08-14 | Gene expression profiles in glomerular diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002324701A1 (en) |
WO (1) | WO2003016476A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7253148B2 (en) | 2003-03-07 | 2007-08-07 | The Research Foundation Of State University Of New York | Human gene with immunoregulatory and anti-proliferative properties |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
US7608395B2 (en) * | 2005-09-15 | 2009-10-27 | Baylor Research Institute | Systemic lupus erythematosus diagnostic assay |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008528A1 (en) * | 1996-08-30 | 1998-03-05 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
US6114123A (en) * | 1999-06-14 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Lipocalin family protein |
-
2002
- 2002-08-14 AU AU2002324701A patent/AU2002324701A1/en not_active Abandoned
- 2002-08-14 WO PCT/US2002/025766 patent/WO2003016476A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003016476A3 (en) | 2003-05-08 |
WO2003016476A2 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002259196A1 (en) | Gene expression profiling | |
AU2002253878A1 (en) | Gene expression profiles in breast tissue | |
AU2002313559A1 (en) | Genes | |
AU2002318298A1 (en) | Defining external parameters in spreadsheets | |
AU2003277910A1 (en) | Ocular gene therapy | |
AU2002365188A1 (en) | Nucleic acid delivery and expression | |
AU2002364078A1 (en) | Gene expression profiles in liver disease | |
AU2001270478A1 (en) | Gene expression in biological conditions | |
AU7606100A (en) | Gene expression profiles | |
GB0122232D0 (en) | Gene expression | |
AU2002355857A1 (en) | Gene associated with bone disorders | |
AU2002324701A1 (en) | Gene expression profiles in glomerular diseases | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AU2003239589A1 (en) | Eta-1 gene and methods for use | |
AU2003217222A1 (en) | In vivo gene transfer | |
AU2002364077A1 (en) | Gene expression profiles in stomach cancer | |
AU2003275946A1 (en) | Gene expression in biological conditions | |
AU2002324792A1 (en) | Amplified gene involved in cancer | |
AU2003241762A1 (en) | Dna shuflling | |
AU2002337325A1 (en) | Gene expression | |
AU2002328502A1 (en) | Novel human bmcc1 gene | |
AU2003290461A1 (en) | Polymorhisms in the dihydropyrimidase gene | |
AUPR799601A0 (en) | Sex specific gene | |
AUPR040700A0 (en) | Sex specific gene | |
AU2002343924A1 (en) | Hepnadc gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |